Related Experiment Video
Updated: May 8, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Atrial Cardiomyopathy Detected by Electrocardiogram: Association with Stroke in a Brazilian Electronic Cohort
Filipe Antunes de Lêu1, Gabriela Miana de Mattos Paixão1, Ana Cecilia Oliveira1
1Universidade Federal de Minas Gerais, Belo Horizonte, MG - Brasil.
Insights
Electrocardiogram (ECG) markers for atrial cardiomyopathy (AC) are linked to increased stroke risk and mortality. These findings highlight the prognostic value of ECG in identifying patients at higher risk for adverse cardiovascular events.
Area of Science:
- Cardiology
- Public Health
- Biomedical Engineering
Background:
- Atrial cardiomyopathy (AC) is a condition detectable by electrocardiogram (ECG).
- AC may significantly contribute to stroke etiology, independent of atrial fibrillation (AF).
Purpose of the Study:
- To investigate the association between ECG markers of AC and stroke-related mortality and hospitalization.
- Specific ECG markers evaluated include prolonged P-wave duration (>120 ms) and P-terminal force in V1 (PTFV1) (>4,000 µV·ms).
Main Methods:
- Retrospective cohort study of 245,588 patients in sinus rhythm, aged ≥40, from Belo Horizonte (2006-2018).
- ECG data were linked to public mortality (SIM) and hospitalization (SIH) databases.
- Cox regression analysis was used to determine hazard ratios (HRs) with incremental adjustments.
Main Results:
- 26.3% of patients had prolonged P-wave duration and 10.1% had elevated PTFV1.
- Prolonged P-wave duration was associated with increased mortality/hospitalization due to stroke (HR 1.24; p<0.001).
- Elevated PTFV1 was also associated with stroke outcomes (HR 1.20; p<0.001).
Conclusions:
- ECG markers of AC demonstrate significant prognostic value.
- These markers are associated with death or hospitalization due to stroke.
- AC markers also predict cardiovascular mortality and incident AF in this cohort.
Background:
Atrial cardiomyopathy (AC) is a condition detectable by electrocardiogram (ECG) that may play a significant role in the pathophysiology of the etiology of strokes, independently of atrial fibrillation (AF).
Objectives:
To evaluate the association between ECG markers of AC (prolonged P-wave duration >120 ms and P-terminal force in V1 (PTFV1) >4,000 µV·ms) as well as the occurrence of mortality and hospitalization due to stroke.
Methods:
This retrospective cohort study included patients from Belo Horizonte who underwent ECGs between 2006 and 2018. Patients aged ≥40 years, in sinus rhythm, and without a previous history of stroke at baseline ECG were included. Clinical and ECG data were linked to mortality (SIM) and hospitalization (SIH) public databases. Cox regression was used to calculate hazard ratios (HRs), and incremental adjustment models for age, sex, cardiovascular risk factors, and left ventricular hypertrophy were employed. Statistical significance was set at p<0.05.
Results:
245,588 patients were included. 26.3% had prolonged P-wave duration >120 ms, and 10.1% had elevated PTFV1 >4,000 µV·ms. Mean follow-up duration was 3.5 years. AC was associated with mortality and hospitalization due to stroke (HR 1.24; 95% CI, 1.12-1.36 for P-wave duration >120 ms; p<0.001; HR 1.20; 95% CI, 1.05-1.38 for PTFV1 >4,000 µV·ms; p<0.001).
Conclusion:
ECG markers of AC are associated with death or hospitalization due to stroke, as well as cardiovascular mortality and incident AF in a large, representative Brazilian cohort, highlighting their prognostic value.
Related Concept Videos
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Cardiomyopathy I: Introduction and Classification
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
